Stem Cell Research (May 2021)

Generation of induced pluripotent stem cell line (IGIBi007-A) from a patient with a novel acromesomelic dysplasia, PRKG2 type (AMDP)

  • Manish Kumar,
  • Saruchi Wadhwa,
  • Nishu Tyagi,
  • Istaq Ahmad,
  • Somesh Kumar,
  • Shakti Sagar,
  • Sana Zahra,
  • Asangla Kamai,
  • Uzma Shamim,
  • Seema Kapoor,
  • Mohammed Faruq

Journal volume & issue
Vol. 53
p. 102340

Abstract

Read online

Biallelic PRKG2 (Protein Kinase, cGMP dependent Type-2) mutations cause a novel acromesomelic dysplasia PRKG2 type. We report generation of induced pluripotent stem cell line from lymphoblastoid cell lines of the patient carrying the reported frameshift mutation (p.Asn164Lysfs*2). The derived iPSC line exhibits all the features of pluripotency, free of major genetic alterations due to reprogramming process and has the capability to differentiate into three germ layers. This iPSC cell line may provide an opportunity to investigate the effect of PRKG2 mutations upon FGF (fibroblast-growth-factor) induced MAPK signalling involved in chondrocyte proliferation in-vitro and may aid in possible therapeutic screening of novel biomolecules.